General Announcement::Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod Capsules, 0.5 Mg

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Mar-2017 13:44:47
Status
New
Announcement Sub Title
Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod Capsules, 0.5 Mg
Announcement Reference
SG170320OTHR497V
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Dear Sir/Madam,

Sub: Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod Capsules, 0.5 Mg.


With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Attachments

Press_SGX.pdf
Total size =186K